Related references
Note: Only part of the references are listed.Distribution of resistant gram-positive organisms across the census regions of the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial
Gerald A. Denys et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2007)
Validation and reproducibility assessment of tigecycline MIC determinations by Etest
Anne Bolmstroem et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004)
Douglas J. Biedenbacha et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Oxazolidinone susceptibility patterns for 2005:: International report from the Zyvox® Annual Appraisal of Potency and Spectrum study
James E. Ross et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Susceptibility of staphylococci and enterococci to antimicrobial agents at different ward levels in four north European countries
Carina Claesson et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2007)
Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial
Ken B. Waites et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Prevalence of inducible clindamycin resistance in staphylococcal isolates at a Korean tertiary care hospital
Hwan Sub Lim et al.
YONSEI MEDICAL JOURNAL (2006)
Functional, biophysical, and structural bases for antibacterial activity of tigecycline
Matthew W. Olson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation
G Kronvall et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Use of the D-test to determine the prevalence of inducible clindamycin-resistant Staphylococcus aureus in a Northern Territory Hospital
JD Pimentel et al.
PATHOLOGY (2006)
Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent Oxyrase to standardize the test method
PA Bradford et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit
HS Sader et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002
SK Bouchillon et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries:: the PEARLS study 2001-2002
SK Bouchillon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
High antibiotic susceptibility among bacterial pathogens in Swedish ICUs - Report from a nation-wide surveillance program using TA(90) as a novel index of susceptibility
H Hanberger et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2004)
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
G Sakoulas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and ireland 2001-2002: The BSAC Bacteraemia Resistance Surveillance Programme
R Reynolds et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals
GS Simonsen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates
D Milatovic et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Classification, identification and subtyping of bacteria based on pyrosequencing and signature matching of 16S rDNA fragments
J Jonasson et al.
APMIS (2002)
Antimicrobial susceptibility patterns of enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems
A Hällgren et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Survey of infections due to Staphylococcus species:: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999
DJ Diekema et al.
CLINICAL INFECTIOUS DISEASES (2001)
Susceptibility of Gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid
CJ Henwood et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Prevalence of vancomycin-resistant enterococci in Europe
MA Schouten et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2000)
Aminoglycoside resistance in enterococci
JW Chow
CLINICAL INFECTIOUS DISEASES (2000)
Glycopeptide resistance in coagulase-negative staphylococci
F Biavasco et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2000)
Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates
AC Gales et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2000)
Share Paper
